I want to speak once again about givinostat and the urgent need for Irish boys living with Duchenne muscular dystrophy to finally gain access to that drug. Tomorrow marks an important point in the reimbursement process and on Thursday, 11 June, it will be exactly one year since the day we gathered outside and inside Leinster House to explain and show the reality for people living with Duchenne muscular dystrophy. Those families are still waiting for access to givinostat. Duchenne is the most common and one of the m…